Pulmonary embolism and diabetes-related-mortality in United States: temporal trends and epidemiologic shifts

Trends in Mortality from Pulmonary Embolism with Hypertension, United States (1999-2023)

Hypertension is a major modifier of PE mortality and requires collective approach to cardiovascular and thromboembolic risk management, and the policymakers and clinicians can focus on hypertension control, facilitating early PE diagnosis, and closing the demographic disparities.

Trends in mortality with pulmonary hypertension and diabetes mellitus as contributing causes of death among U.S. Adults, 1999–2024

Pulmonary Embolism-Attributable Mortality in Patients With Atherosclerotic Cardiovascular Disease in the United States from 2010 to 2023.

BACKGROUND Patients with atherosclerotic cardiovascular disease (ASCVD) are at increased risk of pulmonary embolism (PE) and related mortality, yet contemporary US trends remain incompletely defined. We examined PE-attributable mortality from 2010 to 2023 among patients with ASCVD, stratified by age, sex, race, ethnici...

Trends and disparities in mortality due to coexisting diabetes mellitus and chronic obstructive pulmonary disease among adults in the U.S. (1999-2023): insights from the CDC WONDER database.

BACKGROUND Diabetes mellitus (DM) and chronic obstructive pulmonary disease (COPD) are major health concerns in the United States, with both diseases contributing significantly to mortality. However, the trends in mortality due to the co-occurrence of these conditions from 1999 to 2023 remain underexplored. METHODS T...

Venous thromboembolism mortality trends among us adults with cancer, 1999-2024.

VTE-related mortality among US adults nearly doubled from 1999 to 2024, followed by stabilization after 2022, and persistent disparities across demographic and geographic subgroups underscore the urgent need for equity-oriented prevention strategies.

Trends and disparities in acute myocardial infarction mortality with contributing hyperlipidemia in the United States, 1999-2024.

The rate of AMI deaths in which hyperlipidemia was documented as contributing condition increased significantly over the 26-year study period, with steepest trends observed in males, NH Black, older aged, the southern region, and rural areas.